DRKS00024171CompletedNot Applicable
Investigation of the humoral and cellular immunity against SARS-CoV2 in patients after kidney transplantation in pandemic times - CORENO
niversitätsklinikum Köln0 sites46 target enrollmentStarted: April 19, 2021Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 46
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 16 Years to one (—)
- Sex
- All
Inclusion Criteria
- •Patients after kidney transplantation:
- •- All patients over the age of 16 who are regularly treated in our outpatient clinics
- •- Present written declaration of consent.
- •Patients end stage kidney disease:
- •- All patients who are preparing for a kidney transplant at our center. The minimum age is set at 16 years.
- •- Present written declaration of consent.
- •- Controll group:
- •Present written declaration of consent.
Exclusion Criteria
- •- Persons who are in a dependent / working relationship with the examiners, in particular employees of the clinics and institutes involved
- •- Current infection with SARS-CoV2 (positive PCR result)
- •- Inability to consent, e.g. due to language barriers or mental illness
- •- Placement in an institution based on a judicial or administrative order
- •- Controll group: people who suffer from chronic kidney disease chronic immunosuppression
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Study to the humoral and cellular immuneresponse after influenzavaccination in patients with metastasized RCC or GIST treated with a tyrosine kinase inhibitor(sunitinib or sorafenib)kidney cancer10038363GISTNL-OMON32710niversitair Medisch Centrum Sint Radboud75
Active, not recruiting
Not Applicable
Characterisation of humoral and cellular immunity of low- and high-responder after TBE vaccinatioEUCTR2008-005800-24-ATMedizinische Universität Wien, Institut für Spezifische Prophylaxe und Tropenmedizin84
Active, not recruiting
Phase 1
Characterization of humoral and cellular immunity for tick-borne encephalitis (TBE) vaccination in allogeneic blood and marrow graft recipients: a pilot studyEUCTR2011-002928-41-ATMed. Uni. Wien, Klinik für Innere I52
Active, not recruiting
Phase 1
Detailed analysis of the immune responses after vaccination against Japanese Encephalitis in the elderly.EUCTR2010-020450-33-ATInstitute of Specific Prophylaxis and Tropical Medicine60
Active, not recruiting
Not Applicable
A study of humoral and cellular-mediated immune response in Monoclonal gammopathy of Undetermined Significance after vaccination with trivalent inactivated influenza vaccine (influvac) - mgus-vacc responsMonoclonal Gammopathy of Undetermined significanceEUCTR2010-022693-14-NLuniversity medical centre groningen